|
The emergence of gene and cellular therapeutics has changed the clinical landscape for a variety of disorders and is now ready to do so for neurological diseases.
These therapeutic modalities currently complement and may in time supplant small molecule drugs. This volume comprehensively covers the scientific background, translational efforts, clinical developments and registered biologics that have entered into clinical practice.
Coverage includes types of therapies available and in development, and best practice uses for a variety of neurological disorders including Parkinson’s, Huntington’s, ALS, stroke, spinal cord RP, demyelination, and epilepsy.
|
